Ishikawa Tatsuya, Wanifuchi Hiroshi, Abe Keiichi, Kato Koichi, Watanabe Atsushi, Okada Yoshikazu
Department of Neurosurgery, Saitamaken Saiseikai Kurihashi Hospital, Kuki, Saitama, Japan.
Neurol Med Chir (Tokyo). 2010;50(11):1027-30. doi: 10.2176/nmc.50.1027.
A 51-year-old man presented with a rare case of brain metastasis of malignant pleural mesothelioma (MPM) manifesting as intratumoral hemorrhage. He had undergone several treatments such as left pneumonectomy, pleurectomy, chemotherapy with cis-diamminedichloroplatinum and gemcitabine hydrochloride, and irradiation. Five years later, computed tomography revealed right parietal metastasis with intratumoral hemorrhage and the patient was treated by surgery and irradiation. Six months after the surgery, recurrent intratumoral hemorrhage occurred and a second surgery was performed. MPM has a poor prognosis and brain metastasis is rare, but long-term survival has recently improved through the application of multi-modality approaches. Therefore, the number of opportunities for treating MPM metastasis will increase in the near future. Intratumoral hemorrhage may occur in patients with solitary brain metastasis of MPM, so surgery should be considered as a general candidate treatment for metastatic tumors.
一名51岁男性患者出现罕见的恶性胸膜间皮瘤(MPM)脑转移,表现为肿瘤内出血。他曾接受过多种治疗,如左肺切除术、胸膜切除术、顺铂和盐酸吉西他滨化疗以及放疗。五年后,计算机断层扫描显示右顶叶转移伴肿瘤内出血,患者接受了手术和放疗。术后六个月,再次发生肿瘤内出血,遂进行了第二次手术。MPM预后较差,脑转移罕见,但近年来通过多模式治疗方法,长期生存率有所提高。因此,在不久的将来,治疗MPM转移的机会将会增加。MPM孤立性脑转移患者可能会发生肿瘤内出血,因此手术应被视为转移性肿瘤的一般候选治疗方法。